Drug Delivery
Volume 26, 2019 - Issue 1
Open access
11,639
Views
77
CrossRef citations to date
0
Altmetric
Review
ENHANZE® drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase PH20
Kenneth W. LockeHalozyme Therapeutics, Inc., San Diego, CA, USACorrespondence[email protected]
View further author information
, View further author information
Daniel C. ManevalHalozyme Therapeutics, Inc., San Diego, CA, USAView further author information
& Michael J. LaBarreHalozyme Therapeutics, Inc., San Diego, CA, USAView further author information
Pages 98-106
|
Received 28 Sep 2018, Accepted 19 Nov 2018, Published online: 11 Feb 2019
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.